Catalog # |
Size |
Price |
|
---|---|---|---|
019-28 | 100 µg | $180 |
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2
|
4137.92 | |
| ≥ 95% |
| Exhibits correct molecular weight |
| Insoluble in water. Dissolve in 100-200 µl of DMSO. Then dilute with water or any desired buffer. |
|
Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles. |
| White powder |
| Each vial contains 100 µg of NET peptide. |
Plasma urocortin levels in the diagnosis of ovarian endometriosis.
Florio P, Reis FM, Torres PB, et al. Obstet Gynecol. 2007;110(3):594-600.
High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension.
Florio P, Torricelli M, De falco G, et al. J Hypertens. 2006;24(9):1831-40.
Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies.
Torricelli M, Ignacchiti E, Giovannelli A, et al. Eur J Endocrinol. 2006;154(2):281-5.
Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors.
Takahashi K, Totsune K, Saruta M, et al. Peptides. 2006;27(1):178-82.
High fetal urocortin levels at term and preterm labor.
Florio P, Torricelli M, Galleri L, et al. J Clin Endocrinol Metab. 2005;90(9):5361-5.
Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions.
Saruta M, Takahashi K, Suzuki T, Fukuda T, Torii A, Sasano H. Peptides. 2005;26(7):1196-206.
Expression of urocortin III/stresscopin in human heart and kidney.
Takahashi K, Totsune K, Murakami O, et al. J Clin Endocrinol Metab. 2004;89(4):1897-903.
Urocortin 1 in colonic mucosa in patients with ulcerative colitis.
Saruta M, Takahashi K, Suzuki T, Torii A, Kawakami M, Sasano H. J Clin Endocrinol Metab. 2004;89(11):5352-61.
Differential interactions of urocortin/corticotropin-releasing hormone peptides with the blood-brain barrier.
Kastin AJ, Akerstrom V. Neuroendocrinology. 2002;75(6):367-74.
Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells.
Aggelidou E, Hillhouse EW, Grammatopoulos DK. Proc Natl Acad Sci USA. 2002;99(5):3300-5.
Social Network Confirmation